Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Biomarkers of inflammation and epithelial barrier function in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Soren L Faergeman
  • Hayley Evans
  • Kathrine E Attfield
  • Christiane Desel
  • Subita Balaram Kuttikkatte
  • Mette Sommerlund
  • Lise Torp Jensen
  • Jorgen Frokiaer
  • Manuel A Friese
  • Paul M Matthews
  • Christian Luchtenborg
  • Britta Brügger
  • Annette Bang Oturai
  • Calliope A Dendrou
  • Lars Fugger
View graph of relations

Mixed lineage kinase domain-like (MLKL) is the main executor of necroptosis, an inflammatory form of programmed cell death. Necroptosis is implicated in combating infections, but also in contributing to numerous other clinical conditions, including cardiovascular diseases and neurodegenerative disorders. Inhibition of necroptosis is therefore of therapeutic interest. Here we report two siblings both of whom over the course of 35 years developed a similar progressive, neurodegenerative spectrum disorder characterized by paresis, ataxia and dysarthria. Magnetic resonance imaging of their central nervous system (CNS) revealed severe global cerebral volume loss and atrophy of the cerebellum and brainstem. These brothers are homozygous for a rare haplotype identified by whole genome sequencing carrying a frameshift variant in MLKL, as well as an in-frame deletion of one amino acid in the adjacent fatty acid 2-hydroxylase (FA2H) gene. Functional studies of patient-derived primary cells demonstrated that the variant in MLKL leads to a deficiency of MLKL protein resulting in impairment of necroptosis. Conversely, shotgun lipidomic analysis of the variant in FA2H shows no impact on either the abundance or the enzymatic activity of the encoded hydroxylase. To our knowledge, this is the first report of complete necroptosis deficiency in humans. The findings may suggest that impaired necroptosis is a novel mechanism of neurodegeneration, promoting a disorder that shares some clinical features with primary progressive multiple sclerosis (PPMS) and other neurodegenerative diseases. Importantly, the necroptotic deficiency does not cause symptoms outside the nervous system, nor does it confer susceptibility to infections. Given the current interest in pharmacological inhibition of necroptosis by targeting MLKL and its associated pathways, this strategy should be developed with caution, with careful consideration of the possible development of adverse neurological effects.

Original languageEnglish
JournalCell Death and Differentiation
Volume11
Issue number5
Pages (from-to)303
ISSN1350-9047
DOIs
Publication statusPublished - 1 May 2020

ID: 61516506